GAF Healthcare

Best Hematologists for Chemotherapy For Hematologic Malignancies in Delhi NCR, India

This page lists 1 chemotherapy for hematologic malignancies doctor in Delhi NCR, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 1 chemotherapy for hematologic malignancies doctor in Delhi NCR, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Chemotherapy for Hematologic Malignancies doctors in Delhi NCR, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Chemotherapy for Hematologic Malignancies doctors

Image not available Featured

Dr. Meet Kumar

MBBS, MD, DM (Clinical Hematology), Fellowship in Bone Marrow Transplant
Director & HOD — Hemato-Oncology & Bone Marrow Transplant · Specialty: Hematologist & Bone Marrow Transplant Specialist
Marengo Asia Hospitals Faridabad, India18+ Years experience
Why consider this doctor?
  • 18+ years of experience in Hematologist & Bone Marrow Transplant Specialist
  • Director & Head of Department, Hemato-Oncology & Bone Marrow Transplant, Marengo Asia Hospitals, Faridabad — Present
  • Senior Consultant, BLK Hospital, Delhi
Expertise & Procedures
  • Bone Marrow Transplant (BMT)
  • Autologous Stem Cell Transplant (ASCT)
  • Allogeneic Bone Marrow Transplant
  • Haploidentical Bone Marrow Transplant
  • Matched Unrelated Donor (MUD) Transplant
View all procedures →
Hematologist & Bone Marrow Transplant Specialist Experience: 18+ YearsHospital Affiliation: Marengo Asia HospitalsHospital accreditation: NABH, NABL
View Profile Book a Consultation

Hospitals where these doctors practise

Marengo Asia Hospitals🇮🇳 Faridabad, India
Starting from$8,000

Marengo Asia Hospitals

Est. 2007
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Chemotherapy for Hematologic MalignanciesHematologyCardiac SurgeryCardiology
1+
Doctors for Chemotherapy for Hematologic Malignancies
4.4
54 reviews
450+
Beds
19+
Years Since Founded
Dr. Meet Kumar
View Hospital Profile Enquire / Get Free Opinion

Why consider treatment in India?

Many international patients consider India for acute leukemia treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Chemotherapy for Hematologic Malignancies?

Chemotherapy for hematologic malignancies uses potent anti-cancer drugs, often in combination regimens, to destroy leukemic or malignant blood cells and induce disease remission. It is a cornerstone treatment for acute leukemias and is also used as a conditioning step prior to bone marrow/stem cell transplant. Treatment plans are individualized based on cancer subtype, cytogenetics, and patient fitness, and are typically delivered in cycles under close hematology supervision.

Who may be considered?

Chemotherapy for Hematologic Malignancies may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

A multi-drug regimen given in cycles to achieve remission (induction) followed by consolidation cycles to eliminate residual disease, commonly used for acute myeloid or lymphoblastic leukemia.

3 approaches available for this procedure:

Standard Induction & Consolidation Chemotherapy

Most Common

A multi-drug regimen given in cycles to achieve remission (induction) followed by consolidation cycles to eliminate residual disease, commonly used for acute myeloid or lymphoblastic leukemia.

Comprehensive Investigations

Estimated cost: $500 - $1,200

CBC with differential, bone marrow aspiration and biopsy, cytogenetics and molecular markers, flow cytometry, liver and kidney function tests, ECG, echocardiogram, chest X-ray, HIV/Hepatitis screening

Treatment / Procedure Estimate

Estimated cost in India: $8,000 - $15,000

Stay in India

Pre-procedure stay (outside hospital): ~3-5 days
Hospitalisation: ~25-30 days
Recovery period (outside hospital): ~15 days recommended
Total stay: approx 45 days

Usually Included in Hospital Package

  • Hematologist and nursing care
  • Chemotherapy drugs for the cycle
  • Inpatient isolation room during neutropenic phase
  • Blood/platelet transfusion support
  • Routine monitoring labs during admission

Usually Not Included

  • Subsequent consolidation cycles
  • Growth factor injections (e.g., G-CSF) if needed extra
  • Antifungal/antibiotic therapy for complications
  • Long-term outpatient follow-up visits
  • Travel and accommodation for attendants

Recovery and follow-up

Recovery involves close monitoring for infection and blood count recovery during the neutropenic phase, followed by outpatient follow-up visits with regular CBC and marrow assessments to confirm remission status. Full immune recovery and return to normal activity may take several weeks to a few months depending on the regimen intensity.

Risks

Risks include severe infections due to low white blood cell counts, bleeding from low platelets, nausea, hair loss, organ toxicity, and in rare cases treatment-related mortality, particularly with high-dose regimens. Long-term risks may include secondary malignancies or fertility impairment.

Alternatives

Depending on disease subtype, alternatives may include targeted immunotherapy (e.g., monoclonal antibodies or CAR-T cell therapy), radiation therapy, or supportive/palliative care for patients unfit for intensive chemotherapy. A multidisciplinary tumor board evaluation helps determine the most suitable option.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Complete blood count (CBC) with differential
  • Bone marrow aspiration and biopsy report
  • Cytogenetic and molecular mutation analysis
  • Flow cytometry / immunophenotyping results
  • Liver and kidney function test results
  • ECG and echocardiogram reports
  • Recent CT/PET scan if lymphoma is suspected
  • Prior treatment/chemotherapy history summary

Patient information needed

  • Confirmed diagnosis with subtype/staging details
  • Current performance status and comorbidities
  • Any prior chemotherapy or radiation treatment
  • Known drug allergies or adverse reactions
  • Current medication list including supportive care drugs
  • HLA typing status if transplant is being considered
  • Infection history (hepatitis, HIV, tuberculosis)
  • Availability of a caregiver/attendant during treatment

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Chemotherapy for Hematologic Malignancies) and procedure (Chemotherapy for Hematologic Malignancies) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Chemotherapy for Hematologic Malignancies in Delhi NCR, India

What is Acute Leukemia?
Acute leukemia is a fast-moving cancer that originates in the bone marrow, causing a rapid buildup of abnormal, immature blood cells that interfere with normal blood function. It is classified as either lymphoblastic (ALL) or myeloid (AML) depending on the type of blood cell affected.
What are the symptoms and health risks of Acute Leukemia?
Common symptoms include persistent fatigue, unexplained bruising or bleeding, frequent infections, fever, bone or joint pain, swollen lymph nodes, and unusual paleness. Because acute leukemia progresses quickly, symptoms can appear and worsen over days to weeks rather than months. These symptoms can overlap with many other conditions, so their presence alone is not sufficient to establish a diagnosis — a qualified clinician must evaluate you.
How is Acute Leukemia diagnosed?
Diagnosis typically begins with a full blood count (CBC), which may reveal abnormal blast cell levels, followed by a bone marrow biopsy and aspirate to confirm the presence and percentage of blast cells — with 20% or more blasts generally meeting the threshold for acute leukemia. Further investigations, including immunophenotyping, cytogenetic analysis (karyotyping), and molecular testing for mutations such as FLT3, NPM1, or BCR-ABL, are used to classify the specific subtype and identify risk category (favorable, intermediate, or adverse), all of which directly shape the treatment plan. Lumbar puncture may also be performed to determine whether the central nervous system is involved.
How is Acute Leukemia treated?
Treatment approach depends on the leukemia subtype, cytogenetic and molecular risk profile, the patient's age, overall health, and response to initial therapy. The primary treatment pathway for most patients is intensive chemotherapy — typically delivered in phases of induction, consolidation, and maintenance — with the goal of achieving and sustaining complete remission. For eligible patients, particularly those with high-risk disease or relapse, an allogeneic bone marrow (stem cell) transplant may be recommended, and CAR-T cell therapy is an established option for certain relapsed or refractory cases, notably ALL.
Can Acute Leukemia be treated without a procedure?
Acute leukemia has no meaningful watchful-waiting or lifestyle-only management pathway — the disease progresses rapidly and requires prompt medical intervention. That said, not all treatment is procedural: systemic chemotherapy, targeted therapies (such as tyrosine kinase inhibitors for Philadelphia chromosome-positive disease), and immunotherapy are non-surgical treatment backbones that a clinician may use alone or in combination before determining whether a transplant or cellular therapy is appropriate.
When is Chemotherapy for Hematologic Malignancies considered for Acute Leukemia?
Chemotherapy for Hematologic Malignancies may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Acute Leukemia?
Acute leukemia is primarily evaluated and managed by a hematologist-oncologist specializing in blood cancers. When bone marrow transplantation is under consideration, a transplant hematologist or bone marrow transplant specialist becomes central to the care team, often supported by specialists in infectious disease, transfusion medicine, and clinical pharmacology.
How do I choose a doctor for Acute Leukemia?
When selecting a provider for acute leukemia, look for a hematologist-oncologist with documented experience in your specific leukemia subtype, based at a center with an accredited bone marrow transplant program and access to CAR-T cell therapy, so that the full range of treatment options — including clinical trials — remains available to you if needed. Ask about the center's multidisciplinary tumor board, its remission and transplant outcome data, and how ongoing monitoring and relapse management are coordinated.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.
WhatsApp Us